Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Eugenio Monti
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Disorders
Physiology
Devices
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
23
Piccinini, F
18
Gariboldi, Marzia
13
Tettamanti, Guido
12
Preti, Augusto
12
Venerando, Bruno
11
Ravizza, Raffaella
11
Borsani, Giuseppe
10
Villani, Fabrizio
9
Papini, Nadia
8
Perletti, Gianpaolo
7
Bresciani, Roberto
7
Tringali, Cristina
6
Anastasia, Luigi
6
Manzoni, Marta
5
Arancia, Giuseppe
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Eugenio Monti (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Ravizza Raffaella; Molteni Roberta; Gariboldi Marzia B; Marras Emanuela; Perletti Gianpaolo; Monti Elena
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
European journal of cancer (Oxford, England : 1990) 2009;45(5):890-8.
-
2008: Ravizza Raffaella; Gariboldi Marzia B; Molteni Roberta; Monti Elena
Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Oncology reports 2008;20(3):625-30.
-
2008: Anastasia Luigi; Holguera Javier; Bianchi Anna; D'Avila Francesca; Papini Nadia; Tringali Cristina; Monti Eugenio; Villar Enrique; Venerando Bruno; Muñoz-Barroso Isabel; Tettamanti Guido
Over-expression of mammalian sialidase NEU3 reduces Newcastle disease virus entry and propagation in COS7 cells.
Biochimica et biophysica acta 2008;1780(3):504-12.
-
2007: Gariboldi Marzia B; Ravizza Raffaella; Molteni Roberta; Osella Domenico; Gabano Elisabetta; Monti Elena
Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Cancer letters 2007;258(2):181-8.
-
2007: Manzoni Marta; Colombi Paolo; Papini Nadia; Rubaga Luana; Tiso Natascia; Preti Augusto; Venerando Bruno; Tettamanti Guido; Bresciani Roberto; Argenton Francesco; Borsani Giuseppe; Monti Eugenio
Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio).
The Biochemical journal 2007;408(3):395-406.
-
2007: Zanchetti Gabriele; Colombi Paolo; Manzoni Marta; Anastasia Luigi; Caimi Luigi; Borsani Giuseppe; Venerando Bruno; Tettamanti Guido; Preti Augusto; Monti Eugenio; Bresciani Roberto
Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures.
The Biochemical journal 2007;408(2):211-9.
-
2007: Tringali Cristina; Lupo Barbara; Anastasia Luigi; Papini Nadia; Monti Eugenio; Bresciani Roberto; Tettamanti Guido; Venerando Bruno
Expression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling.
The Journal of biological chemistry 2007;282(19):14364-72.
-
2007: Tringali Cristina; Anastasia Luigi; Papini Nadia; Bianchi Anna; Ronzoni Luisa; Cappellini Maria Domenica; Monti Eugenio; Tettamanti Guido; Venerando Bruno
Modification of sialidase levels and sialoglycoconjugate pattern during erythroid and erytroleukemic cell differentiation.
Glycoconjugate journal 2007;24(1):67-79.
-
2006: Anastasia Luigi; Sampaolesi Maurilio; Papini Nadia; Oleari Diego; Lamorte Giuseppe; Tringali Cristina; Monti Eugenio; Galli Daniela; Tettamanti Guido; Cossu Giulio; Venerando Bruno
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle.
Cell death and differentiation 2006;13(12):2042-51.
-
2006: Banfi Stefano; Caruso Enrico; Buccafurni Loredana; Murano Roberto; Monti Elena; Gariboldi Marzia; Papa Ester; Gramatica Paola
Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling.
Journal of medicinal chemistry 2006;49(11):3293-304.
-
2006: Gariboldi Marzia B; Terni Francesca; Ravizza Raffaella; Meschini Stefania; Marra Manuela; Condello Maria; Arancia Giuseppe; Monti Elena
The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
Free radical biology & medicine 2006;40(8):1409-18.
-
2005: Ravera Mauro; Cassino Claudio; Monti Elena; Gariboldi Marzia; Osella Domenico
Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.
Journal of inorganic biochemistry 2005;99(12):2264-9.
-
2005: Monti Elena; Gariboldi Marzia; Maiocchi Alessandro; Marengo Emilio; Cassino Claudio; Gabano Elisabetta; Osella Domenico
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Journal of medicinal chemistry 2005;48(3):857-66.
-
2005: Bassi Maria Teresa; Manzoni Marta; Bresciani Roberto; Pizzo Maria Teresa; Della Monica Antonella; Barlati Sergio; Monti Eugenio; Borsani Giuseppe
Cellular expression and alternative splicing of SLC25A23, a member of the mitochondrial Ca2+-dependent solute carrier gene family.
Gene 2005;345(2):173-82.
-
2005: Chavas Leonard M G; Tringali Cristina; Fusi Paola; Venerando Bruno; Tettamanti Guido; Kato Ryuichi; Monti Eugenio; Wakatsuki Soichi
Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.
The Journal of biological chemistry 2005;280(1):469-75.
-
2004: Ravizza Raffaella; Gariboldi Marzia B; Passarelli Laura; Monti Elena
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
BMC cancer 2004;4():92.
-
2004: Ravizza Raffaella; Cereda Elena; Monti Elena; Gariboldi Marzia B
The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells.
International journal of oncology 2004;25(6):1817-22.
-
2004: Banfi Stefano; Caruso Enrico; Caprioli Stefania; Mazzagatti Lugi; Canti Gianfranco; Ravizza Raffaella; Gariboldi Marzia; Monti Elena
Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Bioorganic & medicinal chemistry 2004;12(18):4853-60.
-
2004: Manzoni M; Monti E; Bresciani R; Bozzato A; Barlati S; Bassi M T; Borsani G
Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization.
FEBS letters 2004;567(2-3):219-24.
-
2004: Papini Nadia; Anastasia Luigi; Tringali Cristina; Croci Gianluigi; Bresciani Roberto; Yamaguchi Kazunori; Miyagi Taeko; Preti Augusto; Prinetti Alessandro; Prioni Simona; Sonnino Sandro; Tettamanti Guido; Venerando Bruno; Monti Eugenio
The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions.
The Journal of biological chemistry 2004;279(17):16989-95.
-
2004: Monti E; Bassi M T; Bresciani R; Civini S; Croci G L; Papini N; Riboni M; Zanchetti G; Ballabio A; Preti A; Tettamanti G; Venerando B; Borsani G
Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family.
Genomics 2004;83(3):445-53.
-
2004: Tringali Cristina; Papini Nadia; Fusi Paola; Croci Gianluigi; Borsani Giuseppe; Preti Augusto; Tortora Paolo; Tettamanti Guido; Venerando Bruno; Monti Eugenio
Properties of recombinant human cytosolic sialidase HsNEU2. The enzyme hydrolyzes monomerically dispersed GM1 ganglioside molecules.
The Journal of biological chemistry 2004;279(5):3169-79.
-
2003: Gariboldi Marzia B; Ravizza Raffaella; Riganti Loredana; Meschini Stefania; Calcabrini Annarica; Marra Manuela; Arancia Giuseppe; Dolfini Ersilia; Monti Elena
Molecular determinants of intrinsic resistance to doxorubicin in human cancer cell lines.
International journal of oncology 2003;22(5):1057-64.
-
2003: Gariboldi M B; Ravizza R; Petterino C; Castagnaro M; Finocchiaro G; Monti E
Study of in vitro and in vivo effects of the piperidine nitroxide Tempol--a potential new therapeutic agent for gliomas.
European journal of cancer (Oxford, England : 1990) 2003;39(6):829-37.
-
2002: Monti Eugenio; Preti Augusto; Venerando Bruno; Borsani Giuseppe
Recent development in mammalian sialidase molecular biology.
Neurochemical research 2002;27(7-8):649-63.
-
2002: Meschini S; Marra M; Calcabrini A; Monti E; Gariboldi M; Dolfini E; Arancia G
Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.
Toxicology in vitro : an international journal published in association with BIBRA 2002;16(4):389-98.
-
2002: Parolaro Daniela; Massi P; Rubino T; Monti E
Endocannabinoids in the immune system and cancer.
Prostaglandins, leukotrienes, and essential fatty acids 2002;66(2-3):319-32.
-
2001: Gariboldi M B; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.
International journal of oncology 2001;18(6):1245-9.
-
2001: Monti E; Supino R; Colleoni M; Costa B; Ravizza R; Gariboldi M B
Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cells.
Journal of cellular biochemistry 2001;82(2):271-6.
-
2000: Bassi M T; Manzoni M; Monti E; Pizzo M T; Ballabio A; Borsani G
Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.
American journal of human genetics 2000;67(5):1110-20.
-
2000: Gariboldi M B; Rimoldi V; Supino R; Favini E; Monti E
The nitroxide tempol induces oxidative stress, p21(WAF1/CIP1), and cell death in HL60 cells.
Free radical biology & medicine 2000;29(7):633-41.
-
2000: Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
International journal of cancer. Journal international du cancer 2000;87(5):615-28.
-
2000: Monti E; Bassi M T; Papini N; Riboni M; Manzoni M; Venerando B; Croci G; Preti A; Ballabio A; Tettamanti G; Borsani G
Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane.
The Biochemical journal 2000;349(Pt 1):343-51.
-
1999: Monti E; Preti A; Nesti C; Ballabio A; Borsani G
Expression of a novel human sialidase encoded by the NEU2 gene.
Glycobiology 1999;9(12):1313-21.
-
1999: Monti E; Preti A; Rossi E; Ballabio A; Borsani G
Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases.
Genomics 1999;57(1):137-43.
-
1998: Gariboldi M B; Lucchi S; Caserini C; Supino R; Oliva C; Monti E
Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines.
Free radical biology & medicine 1998;24(6):913-23.
-
1997: Dolfini E; Dasdia T; Arancia G; Molinari A; Calcabrini A; Scheper R J; Flens M J; Gariboldi M B; Monti E
Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
British journal of cancer 1997;76(1):67-76.
-
1996: Monti E; Cova D; Guido E; Morelli R; Oliva C
Protective effect of the nitroxide tempol against the cardiotoxicity of adriamycin.
Free radical biology & medicine 1996;21(4):463-70.
-
1995: Piccinini F; Bradamante S; Monti E; Zhang Y K; Janzen E G
Pharmacological action of a new spin trapping compound, 2-phenyl DMPO, in the adriamycin-induced cardiotoxicity.
Free radical research 1995;23(1):81-7.
-
1995: Monti E; Prosperi E; Supino R; Bottiroli G
Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat.
Anticancer research 1995;15(1):193-7.
-
1994: Venerando B; Fiorilli A; Di Francesco L; Chiarini A; Monti E; Zizioli D; Tettamanti G
Cytosolic sialidase from pig brain: a 'protein complex' containing catalytic and protective units.
Biochimica et biophysica acta 1994;1208(2):229-37.
-
1994: Canepari M; Cappelli V; Monti E; Paracchini L; Reggiani C
Delayed doxorubicin cardiomyopathy in the rat: possible role of reduced food intake.
Cardioscience 1994;5(2):101-6.
-
1994: Monti E; Sinha B K
Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines.
Anticancer research 1994;14(3A):1221-6.
-
1993: Bradamante S; Jotti A; Paracchini L; Monti E; Morti E [corrected to Monti E ]
The hydrophilic spin trap, 5,5-dimethyl-1-pyrroline-1-oxide, does not protect the rat heart from reperfusion injury.
European journal of pharmacology 1993;234(1):113-6.
-
1992: Marchesini S; Gatt S; Agmon V; Giudici M L; Monti E
A novel fluorescent pH indicator for the acidic range.
Biochemistry international 1992;27(3):545-50.
-
1992: Bradamante S; Monti E; Paracchini L; Lazzarini E; Piccinini F
Protective activity of the spin trap tert-butyl-alpha-phenyl nitrone (PBN) in reperfused rat heart.
Journal of molecular and cellular cardiology 1992;24(4):375-86.
-
1992: Monti E; Preti A; Novati A; Aleo M F; Clemente M L; Marchesini S
Uptake and metabolism of a fluorescent sulfatide analogue in cultured skin fibroblasts.
Biochimica et biophysica acta 1992;1124(1):80-7.
-
1992: Cova D; De Angelis L; Monti E; Piccinini F
Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-induced cardiotoxicity.
Free radical research communications 1992;15(6):353-60.
-
1991: Villani F; Galimberti M; Monti E; Piccinini F; Poggi P; Lanza E; Rozza A; Favalli L
Effect of flunarizine on the delayed cardiotoxicity of doxorubicin in rats.
Pharmacological research : the official journal of the Italian Pharmacological Society 1991;23(2):195-202.
-
1991: Monti E; Paracchini L; Perletti G; Piccinini F
Protective effects of spin-trapping agents on adriamycin-induced cardiotoxicity in isolated rat atria.
Free radical research communications 1991;14(1):41-5.
-
1991: Villani F; Galimberti M; Zunino F; Monti E; Rozza A; Lanza E; Favalli L; Poggi P
Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione.
Cancer chemotherapy and pharmacology 1991;28(5):365-9.
-
1990: Monti E; Paracchini L; Piccinini F; Rossi C; Formelli F
Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin.
Cancer letters 1990;50(1):79-85.
-
1990: Villani F; Galimberti M; Monti E; Cova D; Lanza E; Rozza-Dionigi A; Favalli L; Poggi P
Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the rat.
Toxicology and applied pharmacology 1990;102(2):292-9.
-
1990: Piccinini F; Monti E; Paracchini L; Perletti G
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin?
Advances in experimental medicine and biology 1990;264():349-52.
-
1990: Monti E; Morazzoni F; Perletti G; Piccinini F
A new approach to the direct detection of free radicals in the intact myocardium.
Free radical research communications 1990;8(3):161-6.
-
1990: Monti E; Paracchini L; Piccinini F; Malatesta V; Morazzoni F; Supino R
Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate.
Cancer chemotherapy and pharmacology 1990;25(5):333-6.
-
1990: Villani F; Galimberti M; Monti E; Piccinini F; Lanza E; Rozza A; Favalli L; Poggi P; Zunino F
Effect of glutathione and N-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicin.
Free radical research communications 1990;11(1-3):145-51.
-
1990: Cova D; Sassano M; Monti E; Piccinini F
DNA damage induced by doxorubicin, 4'-epidoxorubicin and their copper(II) complexes.
Archives of toxicology 1990;64(7):597-8.
-
1989: Lanza E; Rozza A; Favalli L; Monti E; Poggi P; Villani F
The rat model in the comparative evaluation of anthracyclines cardiotoxicity.
Tumori 1989;75(6):533-6.
-
1989: Perletti G; Monti E; Paracchini L; Piccinini F
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity.
Archives internationales de pharmacodynamie et de thérapie 1989;302():280-9.
-
1989: Monti E; Paracchini L; Perletti G
Effect of doxorubicin on calcium receptors of myocardial cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21 Suppl 1():87-8.
-
1989: Bradamante S; Monti E; Paracchini L; Perletti G
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation.
Biochemical and biophysical research communications 1989;163(2):682-8.
-
1989: Fiorilli A; Venerando B; Siniscalco C; Monti E; Bresciani R; Caimi L; Preti A; Tettamanti G
Occurrence in brain lysosomes of a sialidase active on ganglioside.
Journal of neurochemistry 1989;53(3):672-80.
-
1989: Caimi L; Marchesini S; Aleo M F; Bresciani R; Monti E; Casella A; Giudici M L; Preti A
Rapid preparation of a distinct lysosomal population from myelinating mouse brain using Percoll gradients.
Journal of neurochemistry 1989;52(6):1722-8.
-
1989: Cappelli V; Moggio R; Monti E; Paracchini L; Piccinini F; Reggiani C
Reduction of myofibrillar ATPase activity and isomyosin shift in delayed doxorubicin cardiotoxicity.
Journal of molecular and cellular cardiology 1989;21(1):93-101.
-
1988: Villani F; Monti E; Piccinini F; Favalli L; Rozza Dionigi A; Lanza E; Poggi P
Trifluoperazine does not affect doxorubicin cardiotoxicity in the rat.
Anticancer research 1988;8(4):659-63.
-
1988: Monti E; Paracchini L; Piccinini F; Rozza A; Villani F
Effect of calcium inhibitors and calcium mobilizers on doxorubicin accumulation in rat myocardial tissue.
Pharmacological research communications 1988;20(5):369-76.
-
1988: Costa L; Malatesta V; Morazzoni F; Scotti R; Monti E; Paracchini L
Direct detection of paramagnetic species in adriamycin perfused rat hearts.
Biochemical and biophysical research communications 1988;153(1):275-80.
-
1987: Favalli L; Lanza E; Rozza A; Villani F; Poggi P; Piccinini F; Monti E
[Influence of trifluoperazine and flunarizine on the late myocardial toxicity of doxorubicin]
Cardiologia (Rome, Italy) 1987;32(9):1065-9.
-
1987: Villani F; Formelli F; Monti E; Piccinini F; Favalli L; Rozza A; Lanza E; Poggi P
Influence of calcium antagonists on the antitumor activity and the cardiac toxicity of doxorubicin in the rat.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):686-7.
-
1986: Villani F; Monti E; Piccinini F; Favalli L; Lanza E; Rozza Dionigi A; Poggi P
Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats.
Tumori 1986;72(3):323-9.
-
1986: Villani F; Monti E; Piccinini F; Favalli L; Dionigi A R; Lanza E
Effect of doxorubicin on calcium binding sites in guinea-pig heart.
Biochemical pharmacology 1986;35(7):1203-4.
-
1986: Monti E; Piccinini F; Villani F; Favalli L
Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in rat.
Cancer chemotherapy and pharmacology 1986;18(3):289-91.
-
1983: Monti E; Piccinini F; Favalli L; Villani F
Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogs.
Biochemical pharmacology 1983;32(22):3303-6.
-
1983: Monti E; Bossa R; Galatulas I; Favalli L; Villani F; Piccinini F
Interaction between doxorubicin and mitomycin C on mortality and myocardial contractility in guinea pig.
Tumori 1983;69(2):113-6.
Sign-in to see more
